Menu

Oncotelic Therapeutics, Inc. OTLC

Full chart Compare
Set alert

Price alert · OTLC

All alert types
0.01 USD 0.00 (+0.00%)

At closeNov 6, 2026, 4:00 PM EST

0.0129 Day range 0.0135
0.01 52-week range 0.10
YTD
-87.50%
1 year
-90.00%

Revenue & Expenses

Other Income → Expenses: $80.45KExpenses → Selling, General & Admin: $5.02MExpenses → Research & Development: $4.30MExpenses → Interest Expense: $2.00MGross Profit → Expenses: $1.74MRevenue → Gross Profit: $1.74MNet Loss → Expenses: $9.50MOther Income$80.45KGross Profit$1.74MNet Loss$9.50MExpenses$11.32MSelling, General & Admin$5.02MResearch & Development$4.30MInterest Expense$2.00MRevenue$1.74M

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

OTLC annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
9.72M9.13M9.33M4.31M712.74K
756.91K3.66M4.30M1.37M649.75K
4.85M5.47M5.02M2.94M62.98K
-9.72M-9.13M-7.58M-4.31M-712.74K
2.97M2.00M2.00M749.48K0
5.09M-9.39M-9.50M-6.64M-712.74K
5.09M-9.39M-9.50M-6.64M-712.74K
5.09M-9.39M-9.50M-6.64M-712.74K
4.68M-10.52M-9.97M-6.64M-712.74K
-418.38K-1.13M-469.20K00
0.01-0.03-0.11-0.11-0.12
0.01-0.03-0.11-0.11-0.12
0.01-0.03-0.11-0.11-0.12
8.07M-7.39M-7.50M-5.89M-712.74K
8.07M-7.39M-7.50M-5.89M-712.74K
384.08M303.08M88.10M59.96M6.14M
457.30M303.08M88.10M59.96M6.14M